12 Jun 2015 16:00
Immunodiagnostic Systems Holdings plc
Further re Board appointment
12 June 2015
Immunodiagnostic Systems Holdings plc ("IDS"), a leading solution provider to the clinical laboratory diagnostic market, today confirms the following details in respect of the recent announcement that Peter John Williamson, aged 49, will be joining the Board of IDS as a Non-Executive Director with effect from 15 June 2015.
The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:
Current Directorships and Partnerships:
PHS Group Investments Limited
Beneficial House (Birmingham) Regeneration LLP
Bavaria Yachtbau GmbH
Bavaria Holdings GmbH
Strahlenburg Management Ltd
Previous Directorships and Partnerships in last five years:
IBP Actosa Sl
IBP Banninger Italia Srl
IBP GmbH
IBP Instalfittings Sp zoo
ICB IPR Realisations Ltd
ICB Realisations Ltd
Conex Banninger Ltd
CB Holdings Ltd
Gustav (Realisations) Ltd
Everest Conservatories Ltd
Everest Bathrooms Ltd
Everest Home Improvements Ltd
Everest Bedrooms Ltd
Everest Security Systems Ltd
Everest Garage Doors Ltd
Space Age Office Ltd
Jaeger Midco Ltd
Everest Kitchens Ltd
Macsco 30 Ltd
Spicers Ltd
BECAP Spicers (UK) Ltd
Hilary Bidco Ltd
Home Insulation (Jersey) Ltd
Everest (Isle of Man) Ltd
Everest Ltd
Amdega 2011 Ltd
City Link (Properties) No.1 Ltd
City Link Ltd
BECAP City Link (UK) Ltd
Fairline Boats Acquisition Ltd
Fairline Boats Ltd
Spicers (Ireland) Ltd
Better Capital LLP
Better Capital SLP LP
Better Capital 12 SLP LP
Home Installation (UK) Ltd
Everest Home Cover Ltd
Everest Handyman Ltd
Everest Energy Ltd
Everest Windows Ltd
BECAP (Ireland) SLP LP
PHS Group Ltd
Peter Williamson has worked with private equity firms since 2010 often these specialise in working with companies in distressed situations and in some cases the role has required a restructuring through a planned administration/receivership or a planned insolvency to ensure an orderly winding down of the business. While working with these private equity firms, Peter Williamson was appointed as a director of the companies listed below, each of which had administrators, receivers or liquidators appointed at the time he was a director or within twelve months after he ceased to be a director:
Conex Banninger Ltd and CB Holdings Ltd were put into administration in 2011 and later dissolved in 2012. The estimated shortfall for creditors in ICB Realisations Ltd and ICB IPR Realisations Ltd (the successors of these entities) was £69.0 million.
Gustav (Realisations) Ltd (formerly Jaeger Group Ltd) was put into administration in 2012 and liquidated later that year. The estimated shortfall for creditors was £18.4 million.
City Link (Properties) No.1 Ltd and City Link Ltd were both put into administration in December 2014. The estimated shortfall for creditors was £65.4 million in City Link (Properties) No.1 and was £62.5 million in City Link Ltd. Peter Williamson ceased to be a director of these companies in May 2014.
There are no other disclosures required in relation to Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 519 0660 |
Patricio Lacalle, Chief Executive Officer | |
Chris Yates, Group Finance Director
| |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Clare Terlouw |